Post-earnings recap
Reported
Tue, May 6, 2025
EPS actual
$-0.82
EPS est.
$-0.75
EPS surprise
-8.90%
1-day move
-13.29%
Est. EPS
—
Est. Rev
—
Impl. Move
—
IDEAYA Biosciences I reported a larger-than-expected loss per share, which contributed to a significant drop in stock price by 13.29%. The lack of revenue figures and guidance left investors uncertain about the company's future performance. Management's defensive tone suggests they are facing challenges that may require strategic changes.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.82 | N/A | -8.90% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concerns about current market dynamics and their impact on financial performance. They highlighted the importance of adapting strategies to navigate these challenges.
Management acknowledged the challenging market conditions impacting performance.
They emphasized the need for strategic adjustments moving forward.